Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System

  • Christine Y. Turenne
    <!--label omitted: 1-->Department of Medical Microbiology, Faculty of Medicine,1 and
  • Steven E. Sanche
    <!--label omitted: 3-->Division of Infectious Diseases, Royal University Hospital, Saskatoon, Saskatchewan,3 Canada
  • Daryl J. Hoban
    <!--label omitted: 1-->Department of Medical Microbiology, Faculty of Medicine,1 and
  • James A. Karlowsky
    <!--label omitted: 1-->Department of Medical Microbiology, Faculty of Medicine,1 and
  • Amin M. Kabani
    <!--label omitted: 1-->Department of Medical Microbiology, Faculty of Medicine,1 and

書誌事項

公開日
1999-06
権利情報
  • https://journals.asm.org/non-commercial-tdm-license
DOI
  • 10.1128/jcm.37.6.1846-1851.1999
公開者
American Society for Microbiology

この論文をさがす

説明

<jats:title>ABSTRACT</jats:title> <jats:p> Invasive fungal disease often plays an important role in the morbidity and mortality of immunocompromised patients. The poor sensitivity of current fungal blood culture and histological practices has led to the development of highly sensitive and specific molecular techniques, such as the PCR. Sequence variability of the internal transcribed spacer 2 (ITS2) region of fungi is potentially useful in rapid and accurate diagnosis of clinical fungal isolates. PCR with fungus-specific primers targeted toward conserved sequences of the 5.8S and 28S ribosomal DNA (rDNA) results in amplification of the species-specific ITS2 regions, which are variable in amplicon length. We have made use of the ABI PRISM 310 genetic analyzer and the ABI PRISM 310 GeneScan analysis software for the determination of variable size differences of the ITS2 region of clinically important fungi, including <jats:italic>Candida</jats:italic> and non- <jats:italic>Candida</jats:italic> yeasts, <jats:italic>Aspergillus</jats:italic> species, and a variety of dermatophytes. No cross-reaction occurred when samples were tested against human and bacterial genomic DNA. We have found that most clinically significant fungal isolates can be differentiated by this method, and it therefore serves to be a promising tool for the rapid (<7 h) diagnosis of fungemia and other invasive fungal infections. </jats:p>

収録刊行物

被引用文献 (5)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ